Generation Bio Co. Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Generation Bio Co. (GBIO) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-131.67-126.61-136.64-119.15-80.52
Depreciation & Amortization4.935.265.134.533.43
Stock Based Compensation14.6124.3424.4517.868.41
Change in Working Capital-31.4353.541.054.18-1.71
Change in Accounts Receivable-1.220.000.000.000.00
Change in Accounts Payable-0.391.09-1.391.76-1.44
Change in Other Working Capital-15.9310.852.432.42-0.27
Other Operating Activities62.590.030.0417.238.86
Net Cash from Operating Activities-88.56-52.75-102.45-91.82-70.14
Investing Activities
Capital Expenditures-2.40-7.40-8.80-5.96-5.52
Acquisitions0.200.000.000.000.00
Purchases of Investments96.73-2.30-183.71198.90-199.68
Sales/Maturities of Investments232.00403.00-183.71198.90-199.68
Net Cash from Investing Activities94.53-9.70-192.52193.05-205.20
Financing Activities
Common Stock Issued0.4436.551.26215.63217.47
Common Stock Repurchased-0.19-0.57-0.580.000.00
Other Financing Activities-0.19-0.1612.31-0.96-3.23
Net Cash from Financing Activities0.2535.8212.99214.67323.10
Summary
Net Change in Cash6.22-26.63-281.97315.9047.76
Cash at Beginning of Period72.2498.86380.8464.9417.18
Cash at End of Period78.4572.2498.86380.8464.94
Free Cash Flow-90.96-60.14-111.25-97.78-75.66